[1] |
Delanois RE, Mistry JB, Gwam CU, et al. Current epidemiology of revision total knee arthroplasty in the United States[J]. J Arthroplasty, 2017, 32(9): 2663-2668.
|
[2] |
Gwam CU, Mistry JB, Mohamed NS, et al. Current epidemiology of revision total hip arthroplasty in the United States: National inpatient sample 2009 to 2013[J]. J Arthroplasty, 2017, 32(7): 2088-2092.
|
[3] |
Goswami K, Parvizi J, Maxwell Courtney P. Current recommendations for the diagnosis of acute and chronic PJI for hip and knee-cell counts, alpha-defensin, leukocyte esterase, next-generation sequencing[J]. Curr Rev Musculoskelet Med, 2018, 11(3): 428-438.
|
[4] |
Zmistowski B, Karam JA, Durinka JB, et al. Periprosthetic joint infection increases the risk of one-year mortality[J]. J Bone Joint Surg Am, 2013, 95(24): 2177-2184.
|
[5] |
Tarabichi M, Shohat N, Goswami K, et al. Diagnosis of periprosthetic joint infection: the potential of next-generation sequencing[J]. J Bone Joint Surg Am, 2018, 100(2): 147-154.
|
[6] |
Unter EN, Suero EM, Gehrke T, et al. Serum C-reactive protein relationship in high- versus low-virulence pathogens in the diagnosis of periprosthetic joint infection[J]. J Med Microbiol, 2019, 68(6): 910-917.
|
[7] |
Bonanzinga T, Zahar A, Dütsch M, et al. How reliable is the alpha-defensin immunoassay test for diagnosing periprosthetic joint infection? A prospective study[J]. Clin Orthop Relat Res, 2017, 475(2): 408-415.
|
[8] |
Shahi A, Alvand A, Ghanem E, et al. The leukocyte esterase test for periprosthetic joint infection is not affected by prior antibiotic administration[J]. J Bone Joint Surg Am, 2019, 101(8): 739-744.
|
[9] |
Qu PF, Xu C, Fu J, et al. Does serum interleukin-6 guide the diagnosis of persistent infection in two-stage hip revision for periprosthetic joint infection?[J]. J Orthop Surg Res, 2019, 14(1): 354-360.
|
[10] |
Alvand A, Rezapoor M, Parvizi J. The role of biomarkers for the diagnosis of implant-related infections in orthopaedics and trauma [J]. Adv Exp Med Biol, 2017, 971: 69-79.
|
[11] |
Erdemli B, Özbek EA, Basarir K, et al. Proinflammatory biomarkers' level and functional genetic polymorphisms in periprosthetic joint infection[J]. Acta Orthop Traumatol Turc, 2018, 52(2): 143-147.
|
[12] |
Lee YS, Koo KH, Kim HJ, et al. Synovial fluid biomarkers for the diagnosis of periprosthetic joint infection: a systematic review and meta-analysis[J]. J Bone Joint Surg Am, 2017, 99(24): 2077-2084.
|
[13] |
Omar M, Petri M, Hawi N, et al. Higher sensitivity of swab polymerase chain reaction compared with tissue cultures for diagnosing periprosthetic joint infection[J/OL]. J Orthop Surg (HK), 2018, 26(1):1-5.doi: 10.1177/2309499018765296.
|
[14] |
Jun Y, Jianghua L. Diagnosis of periprosthetic joint infection using polymerase chain reaction: an updated systematic review and meta-analysis[J]. Surg Infect (Larchmt), 2018, 19(6): 555-565.
|
[15] |
Salzberg SL, Breitwieser FP, Kumar A, et al. Next-generation sequencing in neuropathologic diagnosis of infections of the nervous system[J]. Neurol Neuroimmunol Neuroinflamm, 2016, 3(4): e251-e260.
|
[16] |
Wilson MR, Naccache SN, Samayoa E, et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing[J]. N Engl J Med, 2014, 370(25): 2408-2417.
|
[17] |
Tarabichi M, Shohat N, Goswami K, et al. Can next generation sequencing play a role in detecting pathogens in synovial fluid?[J]. Bone Joint J, 2018, 100B(2): 127-133.
|
[18] |
Parvizi J, Zmistowski B, Berbari EF, et al. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society[J]. Clin Orthop Relat Res, 2011, 469(11): 2992-2994.
|
[19] |
Margulies M, Egholm M, Altman WE, et al. Genome sequencing in microfabricated high-density picolitre reactors[J]. Nature, 2005, 437(757): 376-380.
|
[20] |
Yoon HK, Cho SH, Lee DY, et al. A review of the literature on culture-negative periprosthetic joint infection: epidemiology, diagnosis and treatment[J]. Knee Surg Relat Res, 2017, 29(3): 155-164.
|
[21] |
Palan J, Nolan C, Sarantos K, et al. Culture-negative periprosthetic joint infections[J]. EFORT Open Rev, 2019, 4(10): 585-594.
|
[22] |
Berbari EF, Marculescu C, Sia I, et al. Culture-negative prosthetic joint infection[J]. Clin Infect Dis, 2007, 45(9): 1113-1119.
|
[23] |
Parikh MS, Antony S. A comprehensive review of the diagnosis and management of prosthetic joint infections in the absence of positive cultures [J]. J Infect Public Health, 2016, 9(5): 545-556.
|
[24] |
Million M, Bellevegue L, Labussiere AS, et al. Culture-negative prosthetic joint arthritis related to Coxiella burnetii[J/OL]. Am J Med, 2014, 127(8): 786.e7-786.e10.doi: 10.1016/j.amjmed.2014.03.013.
|
[25] |
Bingham JS, Hassebrock JD, Christensen AL, et al. Screening for periprosthetic joint infections with ESR and CRP: the ideal cutoffs [J]. J Arthroplasty, 2020, 35(5): 1351-1354.
|
[26] |
Yoon JR, Yang SH, Shin YS. Diagnostic accuracy of interleukin-6 and procalcitonin in patients with periprosthetic joint infection: a systematic review and meta-analysis[J]. Int Orthop, 2018, 42(6): 1213-1226.
|
[27] |
Di Cesare PE, Chang E, Preston CF, et al. Serum interleukin-6 as a marker of periprosthetic infection following total hip and knee arthroplasty[J]. J Bone Joint Surg Am, 2005, 87(9): 1921-1927.
|
[28] |
Shaikh MM, Hermans LE, Van Laar JM. Is serum procalcitonin measurement a useful addition to a rheumatologist's repertoire? A review of its diagnostic role in systemic inflammatory diseases and joint infections[J]. Rheumatology (Oxford), 2015, 54(2): 231-240.
|
[29] |
Glehr M, Friesenbichler J, Hofmann GA, et al. Novel biomarkers to detect infection in revision hip and knee arthroplasties[J]. Clin Orthop Relat Res, 2013, 471(8): 2621-2628.
|
[30] |
Wei G, Steve M, Charles YC. Clinical metagenomic next-generation sequencing for pathogen detection [J]. Annu Rev Pathol, 2019, 14(1): 319-338.
|
[31] |
Talundzic E, Ravishankar S, Kelley J, et al. Next-generation sequencing and bioinformatics protocol for malaria drug resistance marker surveillance[J]. Antimicrob Agents Chemother, 2018, 62(4): e02417-e02474.
|
[32] |
Salipante SJ, Hoogestraat DR, Abbott A, et al. Coinfection of fusobacterium nucleatum and actinomyces israelii in mastoiditis diagnosed by next-generation DNA sequencing[J]. J Clin Microbiol, 2014, 52(5): 1789-1792.
|
[33] |
Thoendel M, Jeraldo PR, Greenwood-Quaintance KE, et al. Comparison of microbial DNA enrichment tools for metagenomic whole genome sequencing[J]. J Microbiol Methods, 2016, 127: 141-145.
|
[34] |
Wilson MR, O′donovan BD, Gelfand JM, et al. Chronic meningitis investigated via metagenomic next-generation sequencing[J]. JAMA Neurol, 2018, 75(8): 947-955.
|
[35] |
Bukowska-Os′ko I, Perlejewski K, Nakamura S, et al. Sensitivity of next-generation sequencing metagenomic analysis for detection of RNA and DNA viruses in cerebrospinal fluid: the confounding effect of background contamination[J]. Adv Exp Med Biol, 2016, 944: 53-62.
|